Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Aug 15, 2025; 17(8): 105818
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.105818
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.105818
Figure 3 Typical cases of perfusion before and after treatment.
A: It depicts the preoperative contrast-enhanced ultrasound of the ablation, revealing pronounced enhancement in the arterial phase of the solid liver S8 mass, suggesting sufficient blood supply to the tumor and significantly enhanced perfusion, typically observed in malignant tumors; B: The arterial phase of the solid liver S8 mass exhibits no enhancement on contrast-enhanced ultrasound post-ablation, indicating complete cessation of blood flow in the tumor region post-treatment, absence of evident perfusion, and either remission or cure of the tumor.
- Citation: Chen LP, Dong Y, He JG, Yang QQ, Hu ZW. Contrast-enhanced ultrasound in evaluating the curative effect of interventional therapy in patients with liver cancer. World J Gastrointest Oncol 2025; 17(8): 105818
- URL: https://www.wjgnet.com/1948-5204/full/v17/i8/105818.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i8.105818